Skip to main content
Premium Trial:

Request an Annual Quote

Watch Out for the Falling Axe

In the latest round of job cuts in the pharma sector, Bristol-Myers Squibb announced it will be cutting 10 percent more of its 37,000-person workforce (they had a 10 percent reduction last year), according to the Wall Street Journal's Health Blog. "Add in weak pipelines of new drugs, tough regulatory scrutiny, and pricing pressure from big purchasers, and it's clear why the industry is seeing round after round of job cut," Jacob Goldstein adds.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.